Compare DOW & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOW | ZBH |
|---|---|---|
| Founded | 1897 | 1927 |
| Country | United States | United States |
| Employees | 34600 | N/A |
| Industry | Major Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 17.6B |
| IPO Year | 2018 | 2001 |
| Metric | DOW | ZBH |
|---|---|---|
| Price | $27.57 | $87.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 27 |
| Target Price | $34.31 | ★ $107.57 |
| AVG Volume (30 Days) | ★ 7.3M | 1.7M |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.08% | 1.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $39,968,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $9.15 | $4.43 |
| Revenue Next Year | N/A | $3.59 |
| P/E Ratio | ★ N/A | $40.22 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $20.67 | $79.12 |
| 52 Week High | $42.74 | $106.88 |
| Indicator | DOW | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 29.99 | 35.80 |
| Support Level | $25.82 | $85.18 |
| Resistance Level | $29.09 | $94.86 |
| Average True Range (ATR) | 0.71 | 2.34 |
| MACD | -0.18 | -0.60 |
| Stochastic Oscillator | 0.55 | 8.36 |
Dow is one of the largest plastics and chemicals producers in the world, ranking in the top five for upstream plastics production, such as polyethylene, or PE, and polypropylene, or PP. It has three reportable segments: packaging and specialty plastics (P&SP), industrial intermediates and infrastructure (II&I), and performance materials and coatings (PM&C). The company traces its roots to 1897 with the founding of the Dow Chemical Company. After a long history of chemical production, Dow strategically merged with DuPont in 2017. In 2019, Dow, DuPont, and Corteva were split to enhance operational focus on the assets of the chemical conglomerate.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.